TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Vifor Pharma Nordiska AB
Closing information (x1000 NOK)
| Closing information | 2024/06 | 2023/06 | 2021/12 |
| Turnover |
331,297
|
430,479
|
237,847 |
| Financial expenses |
934
|
1,398
|
720 |
| Earnings before taxes |
26,304
|
7,773
|
6,986 |
| EBITDA |
26,307
|
9,427
|
7,893 |
| Total assets |
379,310
|
246,431
|
257,995 |
| Current assets |
379,220
|
246,161
|
257,451 |
| Current liabilities |
196,505
|
86,301
|
105,892 |
| Equity capital |
67,431
|
46,229
|
39,953 |
| - share capital |
201
|
198
|
195 |
| Employees (average) |
38
|
46
|
40 |
Financial ratios
| Fiscal year | 2024/06 | 2023/06 | 2021/12 |
| Solvency |
17.8%
|
18.8%
|
15.5% |
| Turnover per employee |
8,718
|
9,358
|
5,946 |
| Profit as a percentage of turnover |
7.9%
|
1.8%
|
2.9% |
| Return on assets (ROA) |
7.2%
|
3.7%
|
3.0% |
| Current ratio |
193.0%
|
285.2%
|
243.1% |
| Return on equity (ROE) |
39.0%
|
16.8%
|
17.5% |
| Change turnover |
-104,752
|
188,920
|
17,596 |
| Change turnover % |
-24%
|
78%
|
8% |
| Chg. No. of employees |
-8
|
6
|
2 |
| Chg. No. of employees % |
-17%
|
15%
|
5% |
Total value of public sale
| Fiscal year | 2024/06 | 2023/06 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.